Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBP2001 in healthy adults
NCT04760743Phase 1Completed
- Sponsor
- SK bioscience
- Start
- Dec 2020
- Primary completion
- Apr 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of NBP2001 in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by SK bioscience. Primary endpoints: Occurrence of immediate systemic reactions at 2 hours, Occurrence of solicited local Adverse Events at 7 days and 10 more. Started Dec 2020; status: completed.
02
Drugs
NBP2001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04760743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04760743.